Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Daiken Medical CoTSE:7775 +0.24%62 Current Ratio is 2.58 as of Mar. 2026, which is 29% above its 10-year median of 2.00. GuruFocus rates TSE:7775 with a GF Score™ of 62/100 and a GF Value™ of 円541.84 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 852 Medical Devices & Instruments companies, Daiken Medical Co ranks better than 52.46% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Daiken Medical Co's current ratio for the quarter that ended in Mar. 2026 was 2.58.
Daiken Medical Co has a current ratio of 2.58. It generally indicates good short-term financial strength.
The historical rank and industry rank for Daiken Medical Co's Current Ratio or its related term are showing as below:
TSE:7775'
s Current Ratio Range Over the Past 10 Years
Min: 1.69 Med: 2 Max: 2.58
Current: 2.58
During the past 13 years, Daiken Medical Co's highest Current Ratio was 2.58. The lowest was 1.69. And the median was 2.00.
TSE:7775's Current Ratio is ranked better than 52.46% of 852
companies
in the Medical Devices & Instruments industry
Industry Median: 2.49
vs TSE:7775: 2.58
Daiken Medical Co (TSE:7775) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Daiken Medical Co Current Ratio Related Terms
Daiken Medical Co Current Ratio Historical Data
* Premium members only.
The historical data trend for Daiken Medical Co's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:7775 vs ISRG, BDX, MDLN: Current Ratio Comparison
For the Medical Instruments & Supplies subindustry, Daiken Medical Co's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Daiken Medical Co Current Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Daiken Medical Co's Current Ratio distribution charts can be found below:
* The bar in red indicates where Daiken Medical Co's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Daiken Medical Co (TSE:7775) has a Current Ratio of 2.58 as of Mar. 2026. This is 29% above median its historical median of 2.00. Over the past decade, Daiken Medical Co's Current Ratio has ranged from 1.69 to 2.58. According to the industry distribution chart, Daiken Medical Co ranks #405 out of 852 companies in the Medical Devices & Instruments industry, placing it in the top 47.5%.
Is Daiken Medical Co's Current Ratio too high?
Daiken Medical Co's current Current Ratio of 2.58 is 29% above median its 10-year median of 2.00. Over the past 10 years, this metric has ranged from a low of 1.69 to a high of 2.58. The Medical Devices & Instruments industry median Current Ratio is 2.49. Daiken Medical Co's value of 2.58 is 3.6% above this industry median. Based on the distribution chart, Daiken Medical Co ranks #405 out of 852 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Daiken Medical Co has a GF Score™ of 62/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Daiken Medical Co's Current Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Daiken Medical Co ranks #405 out of 852 companies for Current Ratio. This puts Daiken Medical Co in the upper half of its industry. The industry median Current Ratio is 2.49. Daiken Medical Co's value of 2.58 is 3.6% above this benchmark. Historically, Daiken Medical Co's own Current Ratio has ranged from 1.69 to 2.58 over the past decade. While the company's 10-year median is 2.00 vs. the industry median of 2.49, Daiken Medical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Medical Devices & Instruments company?
The median Current Ratio among Medical Devices & Instruments companies is 2.49, based on 852 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Daiken Medical Co's current Current Ratio of 2.58 is 3.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median Current Ratio is 2.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Daiken Medical Co's current Current Ratio is 2.58, which is 29% above median its own 10-year median of 2.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Daiken Medical Co stock overvalued right now?
Based on GuruFocus' analysis, Daiken Medical Co (TSE:7775) is currently considered Modestly Undervalued. The stock's GF Value™ is 円541.84, compared to a current price of 円426.00 — trading 21.4% below its estimated fair value. The current Current Ratio is 2.58, which is 29% above median its 10-year median of 2.00 and 3.6% above the Medical Devices & Instruments industry median of 2.49. Daiken Medical Co's overall GF Score™ is 62/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Daiken Medical Co (TSE:7775), the current Current Ratio is 2.58 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Daiken Medical Co (TSE:7775) Overvalued in 2026?
Based on GuruFocus' analysis, Daiken Medical Co stock appears to be undervalued.
The current stock price of 円426.00 is trading 21.4% below its estimated GF Value™ of 円541.84.
GuruFocus considers Daiken Medical Co to be Modestly Undervalued.
Key valuation signals for TSE:7775:
Current Ratio: 2.58 (29% above median its 10-year median of 2.00)
GF Value™: 円541.84 vs. price of 円426.00 (21.4% below fair value)
Industry Position: 3.6% above the Medical Devices & Instruments median (#405 of 852)
No single metric tells the full story. See the TSE:7775 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Daiken Medical Co Ltd manufactures and sells medical equipment. The product line includes - Coopdech syrinjector, Coopdech Syrinjector PCA device, Coopdech Balloonjector, Coopdech Endobronchial blocker tube, Coopdech double-lumen endobronchial tube, Fit fix suction container system, Wet disinfectant mat, and others.
62GF Score
Get the complete analysis for TSE:7775
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7775 has been successfully added to your 
